pharmacie et médicaments – Pharmaciens d'officine - plafonnement des remises sur les génériques

This written question concerns the capping of rebates on generic medicines for community pharmacies in France. It seeks clarification on the financial impact and regulatory framework surrounding these rebates. The question affects community pharmacists, pharmaceutical companies, and potentially patients by influencing the cost and availability of generic drugs.